Munich – CMS advises the sellers of Cardior Pharmaceuticals in the potential acquisition of the company by Novo Nordisk. Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions. It is expected to happen in the second quarter of 2024.A CMS team headed by Lead Partners Stefan-Ulrich Müller, Dr Tilman Weichert and Jörg Schrade advised the sellers of Cardior Pharmaceuticals on all legal aspects of the transaction. Cardior Pharmaceuticals GmbH, based in Hannover, Germany, is a leading clinical-stage bio­phar­ma­ceut­ic­al company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. CMS Germany Stefan-Ulrich Müller, Lead Partner Dr Tilman Weichert, Lead Partner Dr Michael Wangemann, Partner Dr Kai Wallisch, Partner Dr Thomas Mühl, Principal Coun­sel Se­basti­an Hummel, Senior As­so­ci­ate Vikt­or­ia Barthel, Senior As­so­ci­ate Mar­i­elouise Emmer, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Stefan Kühl, Senior Associate Dr Alexander Weinhold, Senior Associate Maria Kucher, Associate Jonas Ohmann, Associate Dr Josephine Doll, Associate Dr Christian Seeburger, Associate Sonja Schanze, Associate, all Corporate/M&A Dr Marie-Luisa Loheide, Associate, Private Clients Jörg Schrade, Lead Partner Eduard Kosavtsev, Senior Associate, both Tax Stefan Lehr, Partner, Antitrust, Competition & Trade Stefan Lüft, Partner, IP Dr Benedikt Forschner, Partner, Labor, Employment & Pensions Dr Markus Kaulartz, Partner Dr Fiona Savary, Counsel Dr Felix Glocker, Senior Associate, all TMC Dr Tilman Niedermaier, Partner Susanne Schwalb, Partner, both Dispute ResolutionPress Con­tact presse@cms-hs. com

Munich – Freudenberg Home and Cleaning GmbH, an international supplier of branded cleaning products and systems as well as laundry care products, has acquired VERMOP Salmon GmbH, a German manufacturer...

Munich – Germany’s oldest privately-owned dairy, Milchwerk Jäger GmbH, is merging with Austrian firm Gmundner Molkerei eGen to create a joint dairy business. The two companies have been working together...

Munich – Croatian company Optimapharm d.o.o. has acquired SSS International Clinical Research GmbH. Optimapharm is an international contract research organisation (CRO) which primarily conducts clinical...

Leipzig – root360 GmbH, a leading provider of managed services focusing on Amazon Web Services, has been acquired by cloud service provider Skaylink, a portfolio company held by Waterland Private Equity...

Munich – Telefónica Deutschland Holding AG has successfully concluded the acquisition of E-Plus. The company, best known in Germany for its O2 brand, has acquired Düs­sel­dorf-based E-Plus Group with...

Munich – Telefónica Deutschland Holding AG has signed an agreement with Dutch tele­com­mu­nic­a­tions group Royal KPN N.V. to acquire Düs­sel­dorf-based mobile service provider E-Plus. KPN, which operates...

Munich – Brückner Technology Holding GmbH has acquired 100% of the shares in Swiss company PackSys Global AG, which in turn owns subsidiaries in Thailand, India and Mauritius.A team led by partners...